We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
GP Nutrition is a nutrition company that creates products meant to deliver sustainable weight loss. This award-winning company was created by Gabriela Peacock, a celebrity nutritionist. It has 13,000 global customers who have bought more than 30,000 packs. In June'19, the company reached trading of £50k per month. It has produced 22 products that are now sold in 30 countries. GP Nutrition has delivered revenue of £377k and an EBITDA of £813,389. Nutrition's vision is to solve the 95% failure rate of diets in the USA and the UK.
days to go: Expired investment: £309,890
A fashion brand in the contemporary luxury accessories market ethically producing handbags to be sold directly to the consumer through e-commerce. Hill & Friends's handbags are manufactured from high quality materials in Western Europe. All leather used is ethically sourced and is a by-product of the food industry. The company sells its products via their own website, through wholesalers and at retailers such as Selfridges, Barneys, Harvey Nichols and Fenwick. Hill & Friends are raising funds to invest in three initiatives. Firstly, they are seeking change in their manufacturing process to utilise more scalable and agile methods that will reduce total expenditure and shorten lead times when reordering high-selling products. Secondly, the company intends to re-platform from Magento to Shopify due to the latter's greater impact on the market. This will result in an improved customer experience and better integrations with affiliate sites. Finally, with the rapid increase of online shopping, Hill & Friends will use the funds raised to invest further in digital marketing by increasing the number of social ads and working alongside a diverse range of online influencers.
days to go: Expired investment: £773,059
Nooro makes cannabidiol (CBD) snack bars. Company founder J.D. Furlong asserts that blending CBD and certain nootropics lead to better cognitive functions in individuals. Nooro also argues that it is the UK's first CBD snack bar seller that is plant-based and gluten-free. The company's products are stocked across 250 retail outlets, cafes, gyms, and delis across the UK. Nooro pivoted to Direct-to-Consumer (D2C) sales during COVID-19 to get better margins. It invested in creating a business model with four distinct revenue streams with 60% earnings coming via e-commerce D2C sales, 15% via digital affiliate sales, 15% via direct sales to partners, and 10% via wholesalers. The company will use the investment to launch an additional three new flavours by February 2021 and grow its business across different verticals.

Pitch Rated

56%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £235,819
EcoPrams is aiming to change the childcare experiences by raising capital to launch and produce plans. It is multi-functional and forward-thinking stroller technology that combines safe swing-seat, toy, and shopping basket that are engineered to address the baby's and parent's needs. The company's unique baby products are raising funds to introduce their first EcoSwingi, pram-system, to address the problems that parents face every day. EcoPrams focus is to launch an internationally recognized brand for parents. It also has a Green Channel Patent which is granted for a storage solution. The company plans to produce its product in China by using position-marketing-plans and e-commerce through internet retail-outlets and independent stores.
days to go: Expired investment: £36,890
Run3D is a biotechnology company that has developed a 3D gait analysis system with the aim to help people identify injuries, deliver better performance, and make better running decisions. 3D gait analysis involves using infrared cameras to track positions of small reflective markers attached to a person in motion, capturing measurable data to help quantify a person's risk of injury, biomechanical efficiency, performance, footwear, and recommend proper diagnosis where necessary. The company plans to use the investment to grow its business.
days to go: Expired investment: Withheld
TToraphene is a forward-thinking company on a mission to revolutionize the packaging industry with its proprietary graphene-based material. This groundbreaking material enhances packaging in terms of strength, flexibility, barrier properties, and recyclability, providing an eco-friendly alternative in the $1.1 trillion packaging sector. Their initial product, a biobased home-compostable waste bin liner with outstanding barrier performance, underscores Toraphene's dedication to sustainability and sets the stage for a variety of innovative solutions to tackle the global plastic waste problem. Moreover, Toraphene has forged strategic alliances, including a Joint Development Agreement (JDA) with a prominent global consumer health brand and an Offtake Agreement, accelerating their efforts to collaborate with industries and offer sustainable packaging solutions.
days to go: Expired investment: £1,204,613
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph